Next Generation Biosurveillance Will Require High-End IT Infrastructure, Says Life Science Insights
FRAMINGHAM, MA – JUNE 16, 2004 -The Department of Homeland Defense is funding a number of novel DNA analysis technologies to provide a network of early warning biodetectors able to detect a broad array of harmful bioagents. Some of these technologies are more likely to succeed than others, according to a new study by Life Science Insights, an IDC company.
Zachary Zimmerman, Ph.D., Senior Research Analyst at Life Science Insights states, "First generation biodetection devices requiring time-consuming DNA amplification and a priori knowledge of pathogens within a sample will not be the most rapid and flexible tools for early warning biodetection devices. In this study, we highlight the next generation devices utilizing novel DNA interrogation technologies that will provide rapid and accurate information required for an actionable network of early warning biodetectors."
As the bioterrorism threat increases, so too grows the need for early warning devices utilizing a secure information technology infrastructure. Current biodetection systems using DNA analysis technologies are complex, costly and time consuming, thereby, inhibiting widespread adoption.
Novel early warning biodetection technologies include single molecule DNA interrogation as well as ultra high-throughput DNA sequencing. Systems utilizing these technologies are expected to provide rapid and accurate results more efficiently thus enabling widespread adoption.
Information technology infrastructure is pivotal to the success of an interconnected web of early warning biodetection devices. Life Science Insights' study, Biodefense: Novel DNA Analysis Technologies for Next-Generation Early Warning Biodetection Systems and Their IT Implications, illustrates that a network of devices distributed throughout post offices, airports, schools and shopping malls will have significant implications for IT infrastructure, requiring plug-in adaptability, speed, accuracy, as well as security and storage.
Although short-term IT requirements for biosurveillance represent only an incremental opportunity, Life Science Insights expects that next generation biodetection devices will provide a strong growth market for high-end IT infrastructure.
This study will be of interest to executives in IT and technology vendors with responsibility for developing strategies in biodefense markets. It also provides key insights for government agencies and the life science investment community. It is one of a series of market studies available to Life Science Insights clients, which present research and analysis on technology and market developments in life science markets.
For a complementary briefing on this report or more details on any of Life Science Insight's information services for business executives, please contact Paul Hands at 508.988.6751.
Life Science Insights, an IDC Company, provides market research, analysis and consulting services to decision makers in life science markets. Clients include pharmaceutical and biotechnology companies, contract research organizations (CROs), government research organizations and technology vendors. Life Science Insight's team of specialist analysts and consultants provide intelligence and advice on technology trends, key market drivers, and end-user intentions. Founded in January 2004, Life Science Insights is headquartered in Framingham, MA. Visit www.life-science-insights.com for more information. IDC is a subsidiary of IDG, the world's leading IT, media, research and exposition company.